Integrated BioPharma, Inc. (OTCMKTS:INBP – Get Free Report) dropped 7.1% on Monday . The company traded as low as $0.33 and last traded at $0.33. Approximately 11,630 shares changed hands during mid-day trading, a decline of 31% from the average daily volume of 16,847 shares. The stock had previously closed at $0.35.
Integrated BioPharma Trading Down 5.6 %
The stock has a market cap of $11.33 million, a PE ratio of 18.70 and a beta of 0.59. The firm has a fifty day simple moving average of $0.33 and a two-hundred day simple moving average of $0.26.
About Integrated BioPharma
Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.
Featured Stories
- Five stocks we like better than Integrated BioPharma
- Investing in Construction Stocks
- 4 Social Media Stocks Set to Gain as TikTok Ban Looms
- Investing in Commodities: What Are They? How to Invest in Them
- How Do Stock Buybacks Affect Shareholders?
- Why Invest in High-Yield Dividend Stocks?
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
Receive News & Ratings for Integrated BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integrated BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
